The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Amiodarone pulmonary toxicity - Amiodarone lung
See under PMID 15062598 (review), 29631763 (Pathology) and Camus, Ph., T.V. Colby, E.C.I. Rosenow, Amiodarone pulmonary toxicity. In Drug-induced and iatrogenic lung disease. P. Camus and E.C. Rosenow, Editors. 2010, Hodder Arnold: London UK
Publications
Iatrogenic pulmonary lesions.
Seminars in diagnostic pathology. 2018;35(4):260-271
Amiodarone pulmonary toxicity.
Clinics in chest medicine. 2004;25(1):65-75
Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry.
Annals of diagnostic pathology. 1997;1(1):47-56
[Interstitial pneumopathy in subjects treated with amiodarone].
Presse medicale (Paris, France : 1983). 1983;12(43):2747-50
Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases.
American journal of clinical pathology. 1987;87(1):7-13
Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2).
Chest. 1988;93(6):1242-8
Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).
Chest. 1988;93(5):1067-75